Evidence map›Paper›PMID 41691046›Full record

ArticleScientific reports2026

Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 suppress polystyrene nanoplastic transcellular permeability and internalization by intestinal epithelial cells.

Kyosuke Kobayashi, Miho Ogawa, Junko Mochizuki, Toshihiro Sashihara

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kyosuke KobayashiWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan. kyousuke.kobayashi@meiji.com.ORCID https://orcid.org/0000-0002-8962-0649
Miho OgawaWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.
Junko MochizukiHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan.
Toshihiro SashiharaWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.ORCID https://orcid.org/0000-0001-7617-0987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plastic is broken into nanoscale particles (nanoplastics) that are harmful to the human body. Nanoplastics orally ingested are internalized into various cells, causing adverse effects such as oxidative stress and apoptosis; however, methods for preventing nanoplastic internalization are lacking. By elucidating this method, it is possible to make a significant contribution to human health. Then, following previous reports that Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 ameliorated barrier dysfunction in the small intestine, we examined their effects on the internalization of polystyrene nanoplastics (PSNPs) in a differentiated Caco-2 monolayer by flow cytometry and immunofluorescent staining. Both yogurt starter strains significantly suppressed fluorescently labeled PSNP internalization by Caco-2 cells, even when the strains were non-viable. Moreover, both strains significantly suppressed the transcellular permeability of PSNPs, suggesting reduced PSNP accumulation in blood vessels and various tissues. Finally, the suppression of PSNP internalization was strain dependent, and both strains were the most potent strains among multiple strains from the same species. This study highlights the potential of L. bulgaricus 2038 and S. thermophilus 1131 for ameliorating the adverse health effects of PSNP intake.

Indexed as

Epithelial CellsIntestinal MucosaLactobacillus delbrueckiiMicroplasticsPolystyrenesStreptococcus thermophilusCaco-2 CellsEndocytosisHumansIntestinal Barrier FunctionPermeabilityTranscytosisYogurtMicroplasticsPolystyrenesCellular endocytosisIntestinal epithelial cellLactobacillus delbrueckii subsp. bulgaricusPolystyrene nanoplasticStreptococcus thermophilusTranscellular permeability

Identifiers

PMID41691046
PMCPMC12996544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.